Skip to nav Skip to content

Clinical Trial Search

296 Clinical Trials Found

Clinical Trial 22713

Disease Site: Any Site
PI: Soyano Muller, Aixa

Clinical Trial 22071

Melanoma Margins Trial (MelMarT-II): A Phase III, multi-centre, multi-national randomised control trial investigating 1cm v 2cm wide excision margins for primary cutaneous melanoma
Disease Site: Other
PI: Zager, Jonathan

Clinical Trial 22305

Disease Site: Breast, Lung, Other Respiratory and Intrathoracic Organs
PI: Soyano Muller, Aixa

Clinical Trial 22484

PRAGMATICA LUNG: A Prospective Randomized Study of Ramucirumab (LY3009806; NSC 749128) plus Pembrolizumab (MK-3475; NSC 776864) versus Standard of Care for Participants Previously Treated with Immunotherapy for Stage IV or Recurrent Non-Small Cell Lung Cancer
Disease Site: Lung
PI: Saltos, Andreas

Clinical Trial 22574

Neoadjuvant and Adjuvant Anti-PD1 or Combinations for Locoregionally Advanced Melanoma
Disease Site: Any Site, Melanoma, skin
PI: Tarhini, Ahmad

Clinical Trial 22617

Disease Site: Breast
PI: Soyano Muller, Aixa

Clinical Trial 23102

Disease Site: Brain and Nervous System
PI: Sandoval-Sus, Jose

Clinical Trial 23103

An Extension Study to Evaluate the Long-term Safety of Rusfertide (PTG-300) in Subjects with Polycythemia Vera
Disease Site: Leukemia, other
PI: Kuykendall, Andrew

Clinical Trial 23116

Disease Site: Eye and Orbit
PI: Khushalani, Nikhil

Clinical Trial 23132

A Phase 1 Study of SGN-EGFRd2 in Advanced Solid Tumors
Disease Site: Colon, Lung, Rectum
PI: Kim, Richard

Clinical Trial 23276

A Phase 2, Randomized, Multicenter, Open-label, Study of FID-007 in Combination With Cetuximab in Patients With Advanced Head and Neck Squamous Cell Carcinoma
Disease Site: Lip, Oral Cavity and Pharynx, Head & Neck
PI: Rabinowits, Guilherme

Clinical Trial 23297

A Randomized Phase 2 Study of ATR Inhibition in Advanced PD-(L)1-refractory Merkel Cell Carcinoma: The MATRiX Trial
Disease Site: Any Site, Other Skin
PI: Brohl, Andrew